Your browser doesn't support javascript.
loading
NRG/RTOG 1122: A phase 2, double-blinded, placebo-controlled study of bevacizumab with and without trebananib in patients with recurrent glioblastoma or gliosarcoma.
Lee, Eudocia Q; Zhang, Peixin; Wen, Patrick Y; Gerstner, Elizabeth R; Reardon, David A; Aldape, Kenneth D; deGroot, John F; Pan, Edward; Raizer, Jeffrey J; Kim, Lyndon J; Chmura, Steven J; Robins, H Ian; Connelly, Jennifer M; Battiste, James D; Villano, John L; Wagle, Naveed; Merrell, Ryan T; Wendland, Merideth M; Mehta, Minesh P.
Afiliação
  • Lee EQ; Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts.
  • Zhang P; NRG Oncology Statistics and Data Management Center, American College of Radiology, Philadelphia, Pennsylvania.
  • Wen PY; Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts.
  • Gerstner ER; Massachusetts General Hospital, Boston, Massachusetts.
  • Reardon DA; Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts.
  • Aldape KD; Toronto General Hospital, Toronto, Ontario, Canada.
  • deGroot JF; The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Pan E; University of Texas Southwestern Medical Center, Dallas, Texas.
  • Raizer JJ; Northwestern University, Evanston, Illinois.
  • Kim LJ; Thomas Jefferson University Hospital, Philadelphia, Pennsylvania.
  • Chmura SJ; University of Chicago Comprehensive Cancer Center, Chicago, Illinois.
  • Robins HI; University of Wisconsin Hospital and Clinics, Madison, Wisconsin.
  • Connelly JM; Froedtert and the Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Battiste JD; University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
  • Villano JL; University of Kentucky, Lexington, Kentucky.
  • Wagle N; University of Southern California, Los Angeles, California.
  • Merrell RT; North Shore University Health System, Evanston, Illinois.
  • Wendland MM; The US Oncology Network-Willamette Valley Cancer Institute, Eugene, Oregon.
  • Mehta MP; Baptist Hospital of Miami, Miami, Florida.
Cancer ; 126(12): 2821-2828, 2020 06 15.
Article em En | MEDLINE | ID: mdl-32154928
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Gliossarcoma / Glioblastoma Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Gliossarcoma / Glioblastoma Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Ano de publicação: 2020 Tipo de documento: Article